Cours Kaneh Bosm Biotechnology Inc Canadian Securities Exchange
Actions
CA4841902022
Pharmacies
CA 2018 | - | CA 2019 | - | Capitalisation | 13,23 M 18,06 M 11,8 M |
---|---|---|---|---|---|
Résultat net 2018 | - 0 0 | Résultat net 2019 | -60 M -81,91 M -53,54 M | VE / CA 2018 * | - |
Trésorerie nette 2018 * | - 0 0 | Trésorerie nette 2019 * | - 0 0 | VE / CA 2019 * | - |
PER 2018 * |
-
| PER 2019 * |
-
| Employés | - |
Rendement 2018 * |
-
| Rendement 2019 * |
-
| Flottant | 0% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15/04/19 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27/04/18 |
Corporate Officer/Principal | - | 25/04/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27/04/18 |
Matthew Fish
BRD | Director/Board Member | - | 29/05/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+15,20% | 2,98 Md | |
-14,63% | 1,27 Md | |
+58,99% | 541 M | |
-7,27% | 436 M | |
-2,51% | 93,65 M | |
-29,77% | 73,4 M | |
+34,83% | 54,57 M |